Market Tracker

10/19 5:09pm ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

14.93
Delayed Data
As of Oct 19
 +0.31 / +2.12%
Today’s Change
14.30
Today|||52-Week Range
44.42
-58.81%
Year-to-Date
guardian investment management Buys Enterprise Products Partners LP, Teva Pharmaceuti...
Oct 19 / GuruFocus News - Paid Partner Content
Bernard Horn Comments on Teva Pharmaceutical
Oct 18 / GuruFocus News - Paid Partner Content
I'm Still No Fan of Teva
Oct 19 / TheStreet.com - Paid Partner Content
Pricing Pressure, Competition Remain Headwinds for Pharma Stocks
Oct 18 / Zacks.com - Paid Partner Content
Teva Submits BLA to FDA for Migraine Candidate Fremanezumab
Oct 19 / Zacks.com - Paid Partner Content
Monarch Capital Management Inc Buys First Merchants Corp, ONEOK Inc, Sells Teva Pharm...
Oct 18 / GuruFocus News - Paid Partner Content
Zacks Market Edge Highlights: Gilead, Biogen, Teva, AbbVie and Aetna
Oct 19 / Zacks.com - Paid Partner Content
Where to Find Value in Healthcare Stocks
Oct 17 / Zacks.com - Paid Partner Content
Zacks Industry Outlook Highlights: Acorda Therapeutics, BioMarin Pharmaceutical, Vale...
Oct 19 / Zacks.com - Paid Partner Content
Allergan (AGN) Loses Restasis Patent Lawsuit, Shares Fall
Oct 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close14.62
Today’s open14.59
Day’s range14.47 - 14.97
Volume14,599,142
Average volume (3 months)19,286,209
Market cap$14.8B
Dividend yield7.40%
Data as of 4:02pm ET, 10/19/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-17.52%
Earnings growth (next 5 years)-0.30%
Revenue growth (last year)+12.01%
P/E ratioNM
Price/Sales1.59
Price/Book0.50

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-4.07-4.61%
TYMETyme Technologies In...+0.37+9.46%
OASMOasmia Pharmaceutica...-0.02-2.15%
Data as of 4:00pm ET, 10/19/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.07
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Kåre Schultz
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts